CAS: 69360-26-5; 2-Cyanobenzenesulfonyl Chloride

该化合物是一种有机化合物,其特点是存在一个硫化氯组和一个附于苯环的硅组,该化合物通常是一种固体或晶体物质,以其反应性而著称,特别是由于硫化氯化物功能组,可进行核循环替代反应,在有机合成中通常用作将硫化物组引入各种基体的试剂,该金属组助长该化合物的极性,并影响其极溶剂中的溶解性.此外,2-氰化物氯化物对湿度敏感,应当谨慎处理,因为它能在水解中释放盐酸.由于化合物具有潜在的刺激性,而且需要妥善储存以保持其稳定性,因此,在与该化合物合作时,安全防范是不可或缺的.总体而言,该物质是合成药物和农用化学品中有价值的中间体.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号81-07-2 糖精 | CAS号63216-04-6 2-(benzylthio)b... | CAS号128-09-6 N-氯代丁二酰亚胺 | CAS号100-51-6 苯甲醇 | CAS号2527-57-3 2,2-二硫代双苯甲酰胺 | CAS号1012-97-1 (1,1-dioxo-2H-1... | CAS号60-29-7 乙醚 | CAS号75-00-3 氯乙烷 | CAS号69360-20-9 1,1-dioxo-2-pro... | CAS号395-46-0 2-cyanobenzenes...

合成工艺路线路线简述

    糖精置于五氯化磷体系中,化学反应生成 2-氰基苯磺酰氯
    参考文献:Process For The Preparation Of 2-Fluorobenzonitrile From Saccharin
    标题:Process For The Preparation Of 2-Fluorobenzonitrile From Saccharin
    摘要:本发明涉及一种制备2-氟苯甲腈的方法.该方法包括以下步骤:(A)在足够条件和时间下加热糖精和五氯化磷,以提供2-氰基苯磺酰氯;(B)将2-氰基苯磺酰氯与碱金属氟化物在溶剂中反应,以在足够条件和时间下提供2-氟苯甲腈.本发明提供了一种制备2-氟苯甲腈的方法,该方法是各种2-氟取代苯的多功能中间体.例如,2-氟苯甲腈的水解会产生2-氟苯甲酸或2-氟苯甲酰胺,而2-氟苯甲腈的还原会产生2-氟苯甲胺.此外,2-氟苯甲腈与有机金属试剂的反应会产生各种2-氟苯基酮.

    海关参考信息

    专利信息


    专利号:US-2022363662-A1
    优先权日:2021-04-20
    标题 :Compounds as lxr agonists
    发明人:PUJALA BRAHMAM; SATHE BALAJI DASHRATH; DANODIA ABHINANDAN; GUPTA ASHU; SONI SANJEEV; KUMAR VIVEK; ANSARI AMANTULLAH; KHAN FARHA; SARKAR ARINDAM; PAYGHAN PAVAN V
    权利人:INTEGRAL BIOSCIENCES PRIVATED LTD
    摘要:The present invention generally discloses compounds having LXR (the liver X receptor) agonistic activity, to the use of such compounds in the treatment of various disorders such as proliferative disorders, Alzheimer's disease, inflammatory diseases, and diseases characterized by defects in cholesterol and lipid metabolism. Specifically, the present invention discloses compound of formula (IA) which exhibit LXR agonist activity, specifically to LXRβ. The invention also discloses method of synthesis of said compounds, method of using said compounds, pharmaceutical compositions comprising said compounds and method of using thereof.

    专利号:US-2022315528-A1
    优先权日:2019-08-21
    标题:Inhibitors of phospholipid synthesis and methods of use
    发明人:GOUW ARVIN; SCHOW STEVEN R; GREENHOUSE ROBERT J; KLINE TONI; FELSHER DEAN W
    权利人:UNIV LELAND STANFORD JUNIOR
    摘要:Inhibitors of Glycerol 3-Phosphate Acyltransferase (GPAT) are provided; and methods of use in the treatment of cancer; and treatment of conditions relating to metabolic syndrome, hyperlipidemia, infection and inflammation.

    专利号:CN-117720498-A
    优先权日:2023-11-03
    标 题 :Synthesis of a new coumarin derivative containing a sulfonamide fragment and preparation method and application of its composition

    专利号:US-8163773-B2
    优先权日:2005-07-11
    标题 :Organic compounds
    发明人:BREITENSTEIN WERNER; ERHARDT CLAUS; MAIBAUM JUERGEN KLAUS; OSTERMANN NILS; ZIMMERMANN JUERG; MASUYA KEIICHI; KONISHI KAZUHIDE; YOKOKAWA FUMIAKI; KANAZAWA TAKANORI; JACOBY EDGAR; MARZINZIK ANDREAS; GROSCHE PHILIPP; KAWAKAMI SHIMPEI
    权利人:BREITENSTEIN WERNER; ERHARDT CLAUS; MAIBAUM JUERGEN KLAUS; OSTERMANN NILS; ZIMMERMANN JUERG; MASUYA KEIICHI; KONISHI KAZUHIDE; YOKOKAWA FUMIAKI; KANAZAWA TAKANORI; JACOBY EDGAR; MARZINZIK ANDREAS; GROSCHE PHILIPP; KAWAKAMI SHIMPEI; NOVARTIS AG
    摘要:The invention relates to 3,5-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,5-substituted piperidine compound, and/or a method of treatment comprising administering a 3,5-substituted piperidine compound, a method for the manufacture of a 3,5-substituted piperidine compound, and novel intermediates and partial steps for its synthesis. The preferred compounds (which can also be present as salts) have the formula I wherein R1, R2, T, R3 and R4 are as defined in the specification.

    专利号:WO-2021035031-A1
    优先权日:2019-08-21
    标 题 :Inhibitors of phospholipid synthesis and methods of use

    专利号:NO-318910-B1
    优先权日:1998-12-23
    标 题:Protease inhibitors, method of synthesis and use thereof, and pharmaceutical composition
    北京嘉盛扬医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chemsun.cn
    企业联系电话:010-63786746,63786429,63787357👤
    📞北京嘉盛扬医药科技有限公司 ⚠️参考联系方式
    联系人:费先生
    电话:010-63786746,63786429,63787357
    手机:13911777236
    传真:010-63787446
    邮箱:market@chemsun.cn
    通信地址: 北京市丰台科技园海鹰路9号2号楼2层
    邮编: 100070
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:北京市丰台科技园海鹰路9号2号楼2层
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Lai, J.; Thomson, B. J.; Sammis, G. M., Science of Synthesis: Modern Strategies in Organofluorine Chemistry , (2024) 1, 2.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知